| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | President & CEO, Director | Common Stock | 550,540 | $308,743 | $0.5608 | 16 Mar 2022 | Direct |
| Generation Bio Co. | Director | Stock Option (right to buy) | 0 | $275,400 | $4.59 | 09 Feb 2026 | Direct |
| Aeglea BioTherapeutics, Inc. | President & CEO, Director | Common Stock | 266,295 | $149,338 | $0.5608 | 16 Mar 2022 | By trusts |
| Generation Bio Co. | Director | Common Stock | 0 | $0 | $5.48 | 09 Feb 2026 | By Quinn Family Irrevocable Trust of 2021 |
| Generation Bio Co. | Director | Common Stock | 0 | $0 | $5.48 | 09 Feb 2026 | Direct |
| Aeglea BioTherapeutics, Inc. | President & CEO, Director | Employee Stock Option (right to buy) | 350,000 | 17 Feb 2022 | Direct | ||
| Kaleido Biosciences, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 30 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | 09 Feb 2026 | 8 | $0 | 4 | Director | 09 Feb 2026, 17:40 |
| GBIO | Generation Bio Co. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| GBIO | Generation Bio Co. | 10 Jan 2025 | 2 | +$203,209 | 4 | Director | 14 Jan 2025, 16:05 |
| GBIO | Generation Bio Co. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:05 |
| GBIO | Generation Bio Co. | 01 Dec 2023 | 1 | +$124,778 | 4 | Director | 05 Dec 2023, 16:30 |
| GBIO | Generation Bio Co. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:15 |
| GBIO | Generation Bio Co. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:05 |
| SYRE | Aeglea BioTherapeutics, Inc. | 16 Mar 2022 | 1 | +$187,705 | 4 | President & CEO, Director | 18 Mar 2022, 06:46 |
| SYRE | Aeglea BioTherapeutics, Inc. | 11 Mar 2022 | 3 | +$280,943 | 4 | President & CEO, Director | 15 Mar 2022, 18:32 |
| SYRE | Aeglea BioTherapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | President & CEO, Director | 22 Feb 2022, 15:57 |
| SYRE | Aeglea BioTherapeutics, Inc. | 31 Dec 2021 | 8 | $0 | 5 | President & CEO, Director | 14 Feb 2022, 16:19 |
| SYRE | Aeglea BioTherapeutics, Inc. | 09 Dec 2021 | 2 | +$198,972 | 4 | President & CEO, Director | 13 Dec 2021, 19:39 |
| GBIO | Generation Bio Co. | 28 Oct 2021 | 2 | $0 | 4 | Director | 29 Oct 2021, 16:01 |
| /report/000120919121044388-quinn-anthony-g-2021-06-30 | Kaleido Biosciences, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 16:22 |
| GBIO | Generation Bio Co. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:08 |